anti-Angiopoietin-Like 3 (ANGPTL3) Anticorps

ANGPTL3 encodes a member of a family of secreted proteins that function in angiogenesis. De plus, nous expédions ANGPTL3 Kits (40) et ANGPTL3 Protéines (35) et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
ANGPTL3 27329 Q9Y5C1
ANGPTL3 30924 Q9R182
ANGPTL3 502970  
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-ANGPTL3 Anticorps sur anticorps-enligne.fr

Showing 10 out of 178 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Livraison Prix Détails
Boeuf (Vache) Lapin Inconjugué WB WB Suggested Anti-ANGPTL3 Antibody Titration:  0.2-1 ug/ml  ELISA Titer:  1:62500  Positive Control:  COLO205 cell lysate 100 μL 2 to 3 Days
$289.00
Détails
Boeuf (Vache) Lapin Inconjugué WB WB Suggested Anti-ANGPTL3 Antibody Titration:  0.2-1 ug/ml  ELISA Titer:  1:1562500  Positive Control:  NCI-H226 cell lysate 100 μL 2 to 3 Days
$289.00
Détails
Humain Lapin Inconjugué WB Anti-ANGPTL3 antibody, Western blotting WB: A549 Cell Lysate Anti-ANGPTL3 antibody, Western blottingWB: A549 Cell Lysate 100 μg 4 to 6 Days
$240.00
Détails
Boeuf (Vache) Lapin Inconjugué WB Western blot analysis of ANGPTL3 expression in HEK293T (A), Raw264.7 (B), PC12 (C) whole cell lysates. 200 μL 13 to 14 Days
$487.50
Détails
Humain Lapin Inconjugué EIA, WB 0.4 mL 6 to 8 Days
$484.00
Détails
Humain Lapin Inconjugué IHC (p), WB WB Image Sample (30 ug of whole cell lysate) A: HepG2 10% SDS PAGE antibody diluted at 1:1000 IHC-P Image Immunohistochemical analysis of paraffin-embedded human hepatoma, using ANGPTL3, antibody at 1:500 dilution. 100 μL 3 to 4 Days
$466.18
Détails
Souris Lapin Inconjugué ICC, IHC, WB Figure. Western Blot; Sample: Human A375 Cells. 100 μg 13 to 16 Days
$342.00
Détails
Humain Lapin Inconjugué ELISA, WB Western blot analysis of Hepg2 whole cell lysates, using ANGPTL3 Antibody. The lane on the left is treated with the antigen-specific peptide. 100 μL 11 to 12 Days
$390.77
Détails
Humain Chèvre Inconjugué ELISA, WB   0.1 mg 6 to 7 Days
$286.39
Détails
Humain Lapin Inconjugué WB Immunohistochemistry of paraffin-embedded mouse kidney using ANGPTL3 Antibody (ABIN1870975) at dilution of 1:100 (40x lens). 100 μL 11 to 13 Days
$366.77
Détails

anti-ANGPTL3 Anticorps mieux référencés

  1. Human Polyclonal ANGPTL3 Primary Antibody pour ELISA, WB - ABIN1169294 : Broxmeyer, Srour, Cooper, Wallace, Hangoc, Youn: Angiopoietin-like-2 and -3 act through their coiled-coil domains to enhance survival and replating capacity of human cord blood hematopoietic progenitors. dans Blood cells, molecules & diseases 2012 (PubMed)

Plus d’anticorps contre ANGPTL3 partenaires d’interaction

Zebrafish Angiopoietin-Like 3 (ANGPTL3) interaction partners

  1. Knockdown of Angptl3 decreases liver size in developing zebrafish.

Human Angiopoietin-Like 3 (ANGPTL3) interaction partners

  1. Reduced secretion and increased uptake of ApoB-containing lipoproteins may contribute to the low LDL-C observed in humans with genetic ANGPTL3 deficiency.

  2. Taken together, our data suggest that serum ANGPTL3 and 4 levels are influenced by nutritional status and fasting and could be involved in the metabolic disturbances present in obesity and anorexia nervosa.

  3. Association of low-density lipoprotein receptor-related protein 1 rs11613352 and angiopoietin-like 3 rs2131925 with hypertension might imply a direct effect at the artery wall.

  4. The present data leads to new insights into the role of ANGPTL3 in glioblastomas and provides an independent predictive factor

  5. The role of ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases is reviewed here.

  6. these results suggest that the DOCK-ANGPTL3 SNPs and their haplotypes were associated with the angiographic severity to coronary artery atherosclerosis and the risk of coronary artery disease (CAD) and ischemic stroke in the Southern Chinese Han population.

  7. Subjects who carried ANGPTL3 sequence variants rs12563308 and rs199772471 had abnormally high total cholesterol and LDL-cholesterol concentrations.

  8. circulating ANGPTL3 and ANGPTL 4 expression was significantly elevated in hepatocellular carcinoma cases compared to chronic hepatitis patients and controls

  9. ANGPTL8 has a functional LPL inhibitory motif, but only inhibits LPL and increases plasma TG levels in mice in the presence of ANGPTL3

  10. Our findings demonstrate that complete ANGPTL3 deficiency associates with highly reduced postprandial lipemia probably due to faster catabolism of intestinally derived lipoproteins, larger expansion of the postprandial FFA pool, and decreased influx of dietary-derived fatty acids into the liver. These results add information on mechanisms underlying hypolipidemia in familial combined hypolipidemia (FHBL2).

  11. participants with heterozygous loss-of-function variants in ANGPTL3 had significantly lower serum levels of triglycerides, HDL cholesterol, and LDL cholesterol than participants without these variants.

  12. ANGPTL3 deficiency is associated with protection from coronary artery disease.

  13. our data shows that ANGPTL3, 4 and 8 are increased in obesity and type 2 diabetes (T2D). ANGPTL8 associates with ANGPTL3 in the non-diabetic subjects while it associated more with ANGPTL4 in the obese and T2D subjects.

  14. ANGPTL3 is specifically correlated with HDL-c, apoA-I, SAA and HDL function in female non-diabetic participants. The decrease of ANGPTL3 level in female T2DM patients might contribute to its weak association to HDL components and function.

  15. The ANGPTL3 gene lies within DOCK7, although the variant is within non-coding regions outside of ANGPTL3, within DOCK7, suggesting complex long-range regulatory effects on gene expression in coronary artery disease.

  16. ANGPTL3 levels were associated with fasting insulin and the homeostasis model assessment of insulin resistance in Korean children.

  17. An ANGPTL3-4-8 model was proposed to explain the variations of lipoprotein lipase (LPL) activity during the fed-fast cycle. Feeding induces ANGPTL8, activating the ANGPTL8-ANGPTL3 pathway, which inhibits LPL in cardiac and skeletal muscles to direct circulating triglycerides (TG) to white adipose tissue; the reverse is true during fasting, which suppresses ANGPTL8 but induces ANGPTL4, thereby directing TG to muscles.

  18. Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion

  19. Novel mutation Y344S found in ANGPTL3 gene in two diabetic patients with familial hypobetalipoproteinemia.

  20. Data suggest that silencing of ANGPTL 3 (angiopoietin-like protein 3) improves insulin sensitivity.

Mouse (Murine) Angiopoietin-Like 3 (ANGPTL3) interaction partners

  1. Reduced secretion and increased uptake of ApoB-containing lipoproteins may contribute to the low LDL-C observed in mice with genetic ANGPTL3 deficiency.

  2. The role of ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases is reviewed here.

  3. ANGPTL8 has a functional LPL inhibitory motif, but only inhibits LPL and increases plasma TG levels in mice in the presence of ANGPTL3

  4. The data suggests that ANGPTL3 is part of the machinery causing dyslipidemia majorily via LPL inhibition in mastitis mice.

  5. Using in vitro ketosis model by glucose starvation, studied inhibition of ketosis by momilactone B. Found momilactone B could regulate the angiopoietin-like-3 (ANGPTL3)-lipoprotein lipase (LPL)pathway, and suppressed the expression of HMGCS2 through the increased expression of STAT5b.

  6. This model suggests a general mechanism by which TAG trafficking is coordinated by lipasin, Angptl3 and Angptl4 at different nutritional statuses.

  7. Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion

  8. The deletion of ANGPTL3 tremendously attenuates proteinuria and protects podocytes from injury in a mouse model of adriamycin-induced nephropathy.

  9. ANGPTL3 has a role in regulating white adipose tissue energy homeostasis but not in liver

  10. Data indicate that expression of Angptl3 in hematopoietic stem cell (HSC) through lentiviral transduction promoted HSC expansion.

  11. Angptl3 could induce actin filament rearrangement, mainly in lamellipodia formation, and that this process was mediated by integrin alpha(V)beta-mediated FAK and PI3K phosphorylation and Rac1 activation.

  12. Furin has a role as the primary in vivo convertase of ANGPTL3 and endothelial lipase in hepatocytes

  13. ANGPTL8, a paralog of ANGPTL3 that arose through duplication of an ancestral DOCK gene, regulates postprandial TAG and fatty acid metabolism by controlling activation of its progenitor, and perhaps other ANGPTLs

  14. Angptl3, as an extrinsic factor, thus supports the stemness of hematopoietic stem cells in the bone marrow niche.

  15. ANGPTL3 expression is upregulated in puromycin-induced podocyte damage and is associated with the reduction of perlecan and agrin expression

  16. a molecular connection between ANGPTL3, lipoprotein lipase, and proprotein convertases

  17. ANGPTL3 to be capable of regulating the motility and permeability of podocytes and that the mechanism of ANGPTL3's regulation could be associated with the altered expression of nephrin.

  18. Like ANGPTL4, ANGPTL3 inhibited nonstabilized LPL but not GPIHBP1-stabilized LPL

  19. ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo

  20. affects VLDL triglyceride clearance by interfering with LPL activity

Pig (Porcine) Angiopoietin-Like 3 (ANGPTL3) interaction partners

  1. First report of molecular cloning and characterization of ANGPTL3 in pigs, which will be helpful for a better understanding of the role of ANGPTLs in lipid metabolism.

ANGPTL3 profil antigène

Profil protéine

This gene encodes a member of a family of secreted proteins that function in angiogenesis. The encoded protein, which is expressed predominantly in the liver, is further processed into an N-terminal coiled-coil domain-containing chain and a C-terminal fibrinogen chain. The N-terminal chain is important for lipid metablism, while the C-terminal chain may be involved in angiogenesis. Mutations in this gene cause familial hypobetalipoproteinemia type 2.

Gene names and symbols associated with ANGPTL3

  • angiopoietin-like 3 (angptl3) anticorps
  • angiopoietin-like 3 (ANGPTL3) anticorps
  • angiopoietin like 3 (ANGPTL3) anticorps
  • angiopoietin-like 3 (Angptl3) anticorps
  • ANG-5 anticorps
  • ANGPT5 anticorps
  • ANGPTL3 anticorps
  • ANL3 anticorps
  • fb60e11 anticorps
  • fb66h02 anticorps
  • FHBL2 anticorps
  • hypl anticorps
  • LOC100230785 anticorps
  • wu:fb60e11 anticorps
  • wu:fb66h02 anticorps
  • zgc:111943 anticorps

Protein level used designations for ANGPTL3

angiopoietin-like 3 , WITHDRAWN: zgc:111943 , angiopoietin-related protein 3-like , angiopoietin 5 , angiopoietin-related protein 3 , angiopoietin-like protein 3 , hypolipidemia

GENE ID SPECIES
114421 Danio rerio
479547 Canis lupus familiaris
695499 Macaca mulatta
742370 Pan troglodytes
100230785 Taeniopygia guttata
100412498 Callithrix jacchus
100442706 Pongo abelii
100473620 Ailuropoda melanoleuca
100616799 Monodelphis domestica
27329 Homo sapiens
30924 Mus musculus
502970 Rattus norvegicus
782603 Bos taurus
445466 Sus scrofa
100189558 Gallus gallus
Fournisseurs de qualité sélectionnés pour anti-ANGPTL3 (ANGPTL3) Anticorps
Avez-vous cherché autre chose?